preexisting pectoral, axillar, thoracic homolateral pain
habitual opioid consumption;
drug-alcoholics addiction ;
ICU postoperative recovery;
kidney failure (creatinin > 2 g/dl, creatinin <clearance 30 ml/h) and/or hepatic failure (cholinesterase < 2000 UI);
cardiac arrhythmias o;
Epilepsy;
Psychiatric, cognitive disorders, mental retardation;
Coagulopathies (INR > 2, activated partial thromboplastin time - aPTT>44 sec);
platelet count less than 100.000/mm3;
BMI > 30;
Allergies to study drugs.

NCT02035904_exc_T1
Condition
thoracic pain
NCT02035904_exc_T2
Qualifier
homolateral
NCT02035904_exc_T3
Condition
axillar pain
NCT02035904_exc_T4
Condition
pectoral pain
NCT02035904_exc_T5
Scope
pectoral, axillar, thoracic pain
NCT02035904_exc_T6
Observation
opioid consumption
NCT02035904_exc_T7
Qualifier
habitual
NCT02035904_exc_T8
Condition
alcoholics addiction
NCT02035904_exc_T9
Condition
diction ; ug-a
NCT02035904_exc_T10
Observation
ICU postoperative recovery
NCT02035904_exc_T11
Condition
kidney failure
NCT02035904_exc_T12
Measurement
creatinin
NCT02035904_exc_T13
Measurement
creatinin <clearance
NCT02035904_exc_T14
Value
30 ml/h
NCT02035904_exc_T15
Value
> 2 g/dl
NCT02035904_exc_T16
Condition
hepatic failure
NCT02035904_exc_T17
Measurement
cholinesterase
NCT02035904_exc_T18
Value
< 2000 UI
NCT02035904_exc_T19
Scope
creatinin > 2 g/dl, creatinin <clearance 30 ml/h
NCT02035904_exc_T20
Condition
cardiac arrhythmias
NCT02035904_exc_T21
Condition
Epilepsy
NCT02035904_exc_T22
Condition
Psychiatric, cognitive disorders
NCT02035904_exc_T23
Condition
mental retardation
NCT02035904_exc_T24
Condition
Coagulopathies
NCT02035904_exc_T25
Measurement
INR
NCT02035904_exc_T26
Value
> 2
NCT02035904_exc_T27
Measurement
activated partial thromboplastin time - aPTT
NCT02035904_exc_T28
Value
>44 sec
NCT02035904_exc_T29
Scope
INR > 2, activated partial thromboplastin time - aPTT>44 sec
NCT02035904_exc_T30
Measurement
platelet count
NCT02035904_exc_T31
Value
less than 100.000/mm3
NCT02035904_exc_T32
Measurement
BMI
NCT02035904_exc_T33
Value
> 30
NCT02035904_exc_T34
Condition
Allergies
NCT02035904_exc_T35
Drug
study drugs